Why Longevity Medicine Still Fails Women and What Needs to Change
Dr Poonam Desai argues that personalized medicine rings hollow while clinical frameworks still use male biology as the default standard.
785 articles
Dr Poonam Desai argues that personalized medicine rings hollow while clinical frameworks still use male biology as the default standard.
A Swiss study of 100,000 cases over 40 years reveals colorectal cancer rising steadily in younger adults, with late diagnoses alarmingly common.
University of Sydney researchers found that cutting fat or animal protein for just four weeks lowered biological age markers in older adults.
A Mass General Brigham trial found multivitamin users aged slower on 5 epigenetic clocks, with the biggest gains in those aging fastest.
Most Americans eat half the fiber needed for optimal gut health. Here's why prebiotic foods dramatically cut disease risk and death.
BIIB080 failed its primary endpoint in Phase 2, yet Biogen sees potential signals worth pursuing in the fight against Alzheimer's tau tangles.
STAT News launches an investigative series exposing how excessive alcohol use remains a leading โ and largely unaddressed โ cause of death.
A landmark Cochrane review of 800,000 men finds PSA screening reduces prostate cancer deaths, shifting the debate on routine testing.
Cyclarity Therapeutics reveals clinical data showing UDP-003 can safely excrete 7-ketocholesterol, a root driver of arterial plaque, from the human body.
Cyclarity's UDP-003 passed its first human trial with zero serious side effects, successfully flushing toxic 7-ketocholesterol through urine.
Hengrui and Kailera will share Phase 1 and 2 clinical data on ribupatide, a dual GLP-1/GIP agonist, at ADA 2025 in June.
Voyager's VY1706 slashed tau protein up to 64% in primate brains after one IV dose, with no adverse effects found.